Please Wait...

Maria Kraus

Translation skills

Main profile

Maria Kraus
Maria Kraus
Executive Vice President Corporate Development & Strategy

Maria is the Executive Vice President, Corporate Development & Strategy at Bioclinica.  She is a member of the executive management team and is responsible for overseeing Bioclinica's strategic growth including mergers and acquisitions.  Maria also leads Business Integration with her in-depth knowledge of the business operations and industry.  Maria joined Bioclinica in 1997 and was formerly the Vice President and Corporate Controller.  She previously led the global accounting and finance, legal, procurement, facilities, human resources and information technology departments.  Maria began her career at PricewaterhouseCoopers in Philadelphia, PA.

She is on the Board of ACRO (Association of Clinical Research Organizations) and serves as Secretary.  She is also a member of the Board of Directors and serves as the Treasurer on the Executive Committee of the Girl Scouts of Eastern Pennsylvania. Maria received her Bachelor's degree in Accounting from Pennsylvania State University and is a Certified Public Accountant in Pennsylvania.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (21 hours ago)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (Yesterday)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (6 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen